ANXA5 and cardiovascular disorder: Labeled annexin A5 has been used in detecting apoptosis in various tumor cells; however, it is insufficient to achieve a detectable target-to-background ratio when used in cardiovascular diseases [14] because annexin A5 is a large protein with limitations, including a suboptimal biodistribution and unfavorable pharmacokinetics [15].